Newsfeeds - Spark Newswire

2 minute read

Bio-Techne And Catamaran Bio Announce Expansion Of Collaboration For CAR-NK Cell Manufacturing Technologies To Include Development Of ‘novel cell expansion technologies for use in the manufacturing of CAR-NK cell therapy products’

Today, 11:53 PM

Bio-Techne Corporation (NASDAQ:TECH) and Catamaran Bio today announced an expansion of their collaboration for the development of cell engineering and cell process technologies for use by Catamaran in the manufacturing

TECH

5 minute read

The Daily Biotech Pulse: Sanofi, Translate Bio Start Early Stage Seasonal Flu Vaccine Study, Dr. Reddy’s Launches Generic Vascepa, Halozyme Strikes Licensing Deal

By Shanthi Rexaline

Today, 11:53 PM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 21)

ABCL

4 minute read

Stocks That Hit 52-Week Highs On Friday

By Benzinga Insights

Today, 11:53 PM

Friday's morning session saw 39 companies set new 52-week highs.

ADBE

1 minute read

Argus Research Maintains Buy on Bio-Techne, Raises Price Target to $490

By Benzinga Newsdesk

Today, 11:53 PM

Argus Research analyst David Toung maintains Bio-Techne (NASDAQ:TECH) with a Buy and raises the price target from $440 to $490.

TECH

5 minute read

The Daily Biotech Pulse: Orphazyme Falters At FDA, Athira’s CEO Placed On Temporary Leave, 5 IPOs

By Shanthi Rexaline

Today, 11:53 PM

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 17)

ABCL

6 minute read

The Daily Biotech Pulse: AstraZeneca, Biogen Face Clinical Trial Disappointments, Novavax Studies Coronavirus-Flu Combo Vaccine, Decision Day For Takeda

By Shanthi Rexaline

Today, 11:53 PM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 14)

ACHL

18 minute read

Stocks That Hit 52-Week Highs On Monday

By Benzinga Insights

Today, 11:53 PM

During Monday's morning session, 255 companies made new 52-week highs.

2 minute read

Kantaro’s Semi-Quantitative Antibody Test Kit Receives Health Canada Authorization Under the COVID-19 Interim Order. BZ NOTE: Kantaro Is A Joint Venture Between Mount Sinai Health System, RenalytixAI And Bio-Techne

By Benzinga Newsdesk

Today, 11:53 PM

Kantaro Biosciences, LLC (Kantaro), a joint venture between the Mount Sinai Health System and RenalytixAI (NASDAQ:RNLX), and its commercial partner Bio-Techne Corporation (NASDAQ:TECH), have received Health Canada

RNLX

32 minute read

Uncategorized

Earnings Scheduled For May 6, 2021

By Benzinga Insights

Today, 11:53 PM

Companies Reporting Before The Bell • ViacomCBS (NASDAQ:VIAC) is projected to report quarterly earnings at $1.22 per share on revenue of $7.30 billion.

AAOI

8 minute read

Uncategorized

Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge

By Shanthi Rexaline

Today, 11:53 PM

Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions.

ABUS